Feline Infectious Peritonitis: A Diagnosis That No Longer Means the End
For decades, a diagnosis of feline infectious peritonitis felt like a death sentence. Vets would deliver the news quietly, owners would cry, and cats would be given weeks at most. That picture has changed dramatically in recent years, and if your cat has been diagnosed with FIP, there is genuine reason for hope.
Understanding what FIP is, how it develops, and what the newer treatment options involve will help you make informed decisions alongside your veterinary team.
What Is FIP and How Does It Develop
FIP is caused by a mutation of the feline coronavirus (FCoV). Feline coronavirus itself is extraordinarily common — estimates suggest that 80 to 90 per cent of cats in multi-cat households carry it at some point. In most cats, infection causes nothing more than mild, self-limiting gastrointestinal symptoms, or no symptoms at all.
The problem arises when the virus mutates within an individual cat's body, acquiring the ability to infect and replicate inside macrophages — white blood cells that are supposed to destroy pathogens. Once that mutation occurs, the resulting virus is what we call FIPV. The immune response triggered by this mutated virus causes inflammation and damage far beyond what the virus itself destroys directly.
Why the mutation happens in some cats and not others remains an area of active research. Genetic factors, immune system status, stress, and viral load all appear to play a role. Young cats under two years and older cats over ten are disproportionately affected.
Recognising the Two Forms of FIP
FIP presents in two main forms, though there is significant overlap.
Wet (Effusive) FIP
This form is characterised by the accumulation of protein-rich fluid in the abdomen or chest cavity. A cat with wet FIP may have a visibly distended belly, laboured breathing if fluid presses on the lungs, lethargy, and a fluctuating fever. This form tends to progress more rapidly.
Dry (Non-Effusive) FIP
The dry form is more insidious. Fluid accumulation is minimal or absent, but granulomatous lesions form on organs including the kidneys, liver, and eyes. Neurological symptoms — seizures, ataxia, behavioural changes — may appear if lesions affect the brain or spinal cord. Ocular FIP can cause uveitis, cloudy eyes, or changes in iris colour.
Many cats show features of both forms simultaneously, which is why the distinction, while useful clinically, is not absolute.
Diagnosis: Why It Can Be Complicated
No single, definitive blood test can confirm FIP with certainty in a living cat. Diagnosis involves combining several findings: clinical signs, blood work showing elevated protein and low albumin-to-globulin ratio, fluid analysis when effusion is present, and antibody titres. PCR testing of fluid or tissue samples can detect viral RNA, which greatly improves diagnostic accuracy.
Immunohistochemistry — identifying the virus within macrophages in tissue samples — remains the gold standard but requires biopsy. Your vet will weigh all available evidence, and in some cases, a trial of treatment itself helps confirm the diagnosis when a cat responds positively.
The Treatment Revolution: Antiviral Drugs for FIP
The most significant development in FIP management has been the emergence of antiviral drugs, particularly nucleoside analogues and protease inhibitors originally developed for human viral diseases.
GS-441524
GS-441524 is a nucleoside analogue that interferes with the replication of the FIP virus. Clinical studies, including those published by researchers at the University of California Davis, have demonstrated remission rates exceeding 80 per cent in cats treated with appropriate doses over a standard 84-day protocol. This was unthinkable a decade ago.
The drug was not initially licensed for veterinary use in many countries, leading to a grey market of compounded and imported formulations. Licensing has progressed in several regions, and access through legitimate veterinary channels is improving.
Molnupiravir and Other Agents
Molnupiravir, an antiviral developed during the COVID-19 pandemic, has shown activity against FIP virus in laboratory settings and early clinical use. Research is ongoing, and it is not yet a standard first-line treatment, but its oral availability makes it a candidate for future protocols.
What Treatment Looks Like in Practice
Treatment typically involves daily injections or oral administration of antiviral medication for a minimum of 12 weeks. Neurological and ocular forms often require higher doses and longer treatment courses. Regular monitoring — blood work, clinical assessment, and sometimes imaging — tracks response. Cats that achieve sustained remission after completing the protocol are considered potentially cured, though relapses do occur and must be retreated promptly.
- Standard treatment duration is 84 days minimum
- Neurological cases may require 12 to 24 weeks or longer
- Follow-up monitoring continues for at least 12 months post-treatment
- Relapse rates vary by form but respond well to retreatment in most cases
Supportive Care Alongside Antivirals
Antivirals are the backbone of treatment, but supportive care remains essential. Corticosteroids such as prednisolone are often used in the initial stages to dampen the inflammatory response and help the cat feel well enough to eat and engage with life. Appetite stimulants, nutritional support, and drainage of effusive fluid when it causes distress all contribute to quality of life during the treatment period.
Nutrition matters considerably. Cats with FIP often have suppressed appetites, and maintaining caloric intake supports immune function and organ recovery. High-protein, palatable diets are generally recommended, and assisted feeding may be necessary in some cases.
Looking Forward: What Owners Should Know
If your cat has been diagnosed with FIP, seek a vet experienced with the current antiviral protocols. Treatment is not cheap, and access varies by location, but the landscape is genuinely different from what it was even five years ago. Organisations such as the FIP Warriors community and university veterinary hospitals can direct owners towards current resources and legitimate treatment sources.
The science continues to move quickly. Oral formulations are improving, combination protocols are being studied, and our understanding of which cats respond best to which agents is deepening. For a disease that was once universally fatal, the progress has been remarkable — and cats are surviving to live full, healthy lives after FIP treatment in ways that were simply not possible before.